BioPoly

About:

BioPoly focuses in the development of orthopedic devices for the sports medicine, orthopedics, and spinal markets.

Website: http://biopolyortho.com

Twitter/X: biopolyortho

Description:

BioPoly engages in the research, design, and manufacture of orthopedic devices for use in the sports medicine, orthopedics, and spinal markets. It provides a treatment option for painful cartilage lesions between the extremes of biological solutions and total joint replacement. It offers BioPoly RS Knee System, a femoral condyle partial resurfacing device that is implanted utilizing a reusable instrument kit; and BioPoly-RS Partial Resurfacing Knee Implant, a long term surgically invasive device for the replacement of focal osteochondral defects in the knee ranging from 0.8-3.1 sq. cm. BioPoly was formerly known as BioPoly RS. The company was incorporated in 2007 and is based in Fort Wayne, Indiana. The company operates as a subsidiary of Schwartz Biomedical.

Total Funding Amount:

$15.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Fort Wayne, Indiana, United States

Founded Date:

2005-01-01

Contact Email:

info(AT)biopolyortho.com

Founders:

Herb Schwartz

Number of Employees:

1-10

Last Funding Date:

2023-01-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai